Reaction Details |
| Report a problem with these data |
Target | Prostaglandin E2 receptor EP4 subtype |
---|
Ligand | BDBM50233520 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1650985 (CHEMBL4000119) |
---|
IC50 | >10000±n/a nM |
---|
Citation | Sandham, DA; Barker, L; Brown, L; Brown, Z; Budd, D; Charlton, SJ; Chatterjee, D; Cox, B; Dubois, G; Duggan, N; Hall, E; Hatto, J; Maas, J; Manini, J; Profit, R; Riddy, D; Ritchie, C; Sohal, B; Shaw, D; Stringer, R; Sykes, DA; Thomas, M; Turner, KL; Watson, SJ; West, R; Willard, E; Williams, G; Willis, J Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP ACS Med Chem Lett8:582-586 (2017) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Prostaglandin E2 receptor EP4 subtype |
---|
Name: | Prostaglandin E2 receptor EP4 subtype |
Synonyms: | PE2R4_HUMAN | PGE receptor EP4 subtype | PGE2 receptor EP4 subtype | PTGER2 | PTGER4 | Prostaglandin E2 receptor | Prostanoid EP4 receptor |
Type: | Enzyme |
Mol. Mass.: | 53134.53 |
Organism: | Homo sapiens (Human) |
Description: | P35408 |
Residue: | 488 |
Sequence: | MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCG
LAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLA
INHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTA
HAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRG
HPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQP
SLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSG
QHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPG
MGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSET
LNLSEKCI
|
|
|
BDBM50233520 |
---|
n/a |
---|
Name | BDBM50233520 |
Synonyms: | Fevipiprant | NVP-QAW039 | QAW039 |
Type | Small organic molecule |
Emp. Form. | C19H17F3N2O4S |
Mol. Mass. | 426.409 |
SMILES | Cc1c(CC(O)=O)c2cccnc2n1Cc1ccc(cc1C(F)(F)F)S(C)(=O)=O |
Structure |
|